The Long and Short of CerviLenz Prenatal Technology
Cervilenz has developed an innovative low cost, single use medical device that accurately measures a pregnant woman’s cervical length, which is the best indicator of preterm birth risk.
Cervilenz has developed an innovative low cost, single use medical device that accurately measures a pregnant woman’s cervical length, which is the best indicator of preterm birth risk.
In this age where more and more modes of communication are being created, it is natural to find innovative ways to connect health professionals and patients.
Provectus Pharmaceuticals develops a powerful drug pipeline with minimal side effects, including a cancer drug that targets cancer tissue, as well as…
OneMedPlace, producers of the OneMedForum investment conference has partnered with Proactive Investors, a UK based Investment Portal as a means to help growth companies gain […]
Strategic News Service recently announced that Cynvenio Biosystems has been selected as a 2011 FiReStarter company, to be featured at its annual Future in Review technology conference.
Biovista announced recently that it has entered into a research collaboration agreement with Novartis.
WaferGen Biosystems is a leader in the development, manufacture, and sale of state-of-the-art systems for genome analysis for the life science and pharmaceutical industries.
Bio-Path Holdings has developed a powerful drug delivery technology that utilizes cell-like drug carriers, termed liposomes, which avoid drug breakdown.
ADS Biotechnology has developed a breakthroughtechnology that upon administration immediately prevents any further blood vessel leakage, thereby effectively treating and reversing CLS.
Copyright © 2024 | WordPress Theme by MH Themes